Work

Polarized dendritic cells as cancer vaccines: Directing effector-type T cells to tumors

Year: 2010

Type: review

Source: Seminars in Immunology

DOI: 10.1016/j.smim.2010.03.002

Authors: Pawel Kalinski, Hideho Okada

Institutions: University of Pittsburgh, UPMC Hillman Cancer Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: University of Pittsburgh, National Institutes of Health, U.S. Public Health Service, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Center for Advancing Translational Sciences

Awards: G1426609917, G1765966478, Regulation of DC Activity by Memory and Effector CD8+ T Cells, G2417703257, G2840147485, Integrating NK and DC into Cancer Therapy, Novel Strategies for Brain Tumor Therapy, G3670995956, Directing Tumor-specific T cells to Tumors, G556665557, University of Pittsburgh Clinical and Translational Science Institute, SPORE in Skin Cancer, Polarized DC as Melanoma Vaccine: Phase 1 Evaluation, G7312517082, G7318366103, Novel Immunotherapy of Glioma using miR-17-92 Transfected T Cells

OpenAlex ID: W1991331687

FWCI: 0.653

Cites: 187

Cited by: 71

Related to: 10